22 /100
LOW RISK
Score updated May 28, 2026

MET-PA — MetLife, Inc. Dilution Risk Tracker

Track MET-PA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MET-PA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
32
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for MET-PA.
🔔 Track MET-PA — Get forecast alerts →

💹 Market Data

Market CapN/A
Shares Outstanding986.84M
Float537.44M
Cash$27.64B
Debt$19.28B
Short InterestN/A

🏛 Institutional Holdings

1426 institutional holders · 517.66M shares
#1 VANGUARD GROUP INC 72.56M shares
#2 Dodge & Cox 52.25M shares
#3 BlackRock, Inc. 50.03M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short interest data updating...

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track MET-PA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MET-PA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for MET-PA
📊 MET-PA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MET-PA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.